Human Reproduction, Vol. 17, No. 8, 1987-1993,
August 2002
© 2002 European Society of Human Reproduction and Embryology
Single dose pharmacokinetics and effects on follicular growth and serum hormones of a long-acting recombinant FSH preparation (FSH-CTP) in healthy pituitary-suppressed females
1 Dinox Medical Investigations, Groenewoudseweg 317, 6524 TX, Nijmegen and 2 N.V. Organon, Molenstraat 110, P.O.Box 20, 5340 BH, Oss, The Netherlands
BACKGROUND: A long-acting FSH preparation has been developed by site-directed mutagenesis and gene transfer techniques. METHODS: In this open-label trial, we investigated the pharmacokinetic and pharmacodynamic properties of FSH-CTP (corifollitropin alpha, Org 36286) in healthy female volunteers. Twenty-four subjects were treated with a high-dose oral contraceptive (OC) to suppress pituitary function. A single dose of 15, 30 or 60 µg FSH-CTP was injected (s.c., eight subjects per dose group) and seven of these 24 subjects were subsequently treated with a single dose of 120 µg. RESULTS: Maximum serum FSH-CTP concentrations (0.42, 0.66, 1.49 and 3.27 ng/ml after administration of 15, 30, 60 and 120 µg Org 36286 respectively) were reached between 36 and 48 h after injection and t1/2 varied between 60 and 75 h. Dose proportionality was shown across the studied dose range, whereas tmax and t1/2 were dose independent. In most subjects follicular growth was observed; the number and maximum diameter of the follicles increased with the dose. Follicles with a diameter 
8.0 mm were observed only in the 60 and 120 µg dose groups, diameters between 12.0 and 15.9 mm occurred only in the 120 µg group. Serum LH and 17ß-oestradiol levels remained low due to profound pituitary suppression whereas inhibin-B levels increased with dose. Maximum mean inhibin-B levels were 30.4, 322.7 and 1059.3 pg/ml in the 30, 60 and 120 µg dose group respectively. The preparation was safe and well tolerated, and no FSH-CTP antibody formation was observed. CONCLUSIONS: The pharmacokinetics of FSH-CTP were shown to be proportional with the dose. The elimination half-life was approximately two times longer than that of rFSH. A single dose of FSH-CTP was shown to be safe and able to induce multiple follicular growth accompanied by a dose-dependent rise in serum inhibin-B concentrations.
Key words: FSH-CTP/infertility/long-acting/pharmacodynamics/pharmacokinetics
3 To whom correspondence should be addressed. E-mail: dinox{at}molyvos.net
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  P. Devroey, R. Boostanfar, N.P. Koper, B.M.J.L. Mannaerts, P.C. IJzerman-Boon, B.C.J.M. Fauser, and on behalf of the ENGAGE Investigators A double-blind, non-inferiority RCT comparing corifollitropin alfa and recombinant FSH during the first seven days of ovarian stimulation using a GnRH antagonist protocol Hum. Reprod., August 14, 2009; (2009) dep291v1. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B.C.J.M. Fauser, B.M.J.L. Mannaerts, P. Devroey, A. Leader, I. Boime, and D.T. Baird Advances in recombinant DNA technology: corifollitropin alfa, a hybrid molecule with sustained follicle-stimulating activity and reduced injection frequency Hum. Reprod. Update, May 1, 2009; 15(3): 309 - 321. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
The Corifollitropin Alfa Dose-finding Study Group A randomized dose-response trial of a single injection of corifollitropin alfa to sustain multifollicular growth during controlled ovarian stimulation Hum. Reprod., November 1, 2008; 23(11): 2484 - 2492. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Fares, S. Ganem, T. Hajouj, and E. Agai Development of a Long-Acting Erythropoietin by Fusing the Carboxyl-Terminal Peptide of Human Chorionic Gonadotropin {beta}-Subunit to the Coding Sequence of Human Erythropoietin Endocrinology, October 1, 2007; 148(10): 5081 - 5087. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. K. Trousdale, S. V. Pollak, J. Klein, L. Lobel, Y. Funahashi, N. Feirt, and J. W. Lustbader Single-Chain Bifunctional Vascular Endothelial Growth Factor (VEGF)-Follicle-Stimulating Hormone (FSH)-C-Terminal Peptide (CTP) Is Superior to the Combination Therapy of Recombinant VEGF plus FSH-CTP in Stimulating Angiogenesis during Ovarian Folliculogenesis Endocrinology, March 1, 2007; 148(3): 1296 - 1305. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. S. Macklon, R. L. Stouffer, L. C. Giudice, and B. C. J. M. Fauser The Science behind 25 Years of Ovarian Stimulation for in Vitro Fertilization Endocr. Rev., April 1, 2006; 27(2): 170 - 207. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. E. Messinis Ovulation induction: a mini review Hum. Reprod., October 1, 2005; 20(10): 2688 - 2697. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S.C. Low, S.L. Nunes, A.J. Bitonti, and J.A. Dumont Oral and pulmonary delivery of FSH-Fc fusion proteins via neonatal Fc receptor-mediated transcytosis Hum. Reprod., July 1, 2005; 20(7): 1805 - 1813. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. H. Balen, A. G. Mulders, B. C. Fauser, B. C. Schoot, M. A. Renier, P. Devroey, M. J. Struijs, and B. M. Mannaerts Pharmacodynamics of a Single Low Dose of Long-Acting Recombinant Follicle-Stimulating Hormone (FSH-Carboxy Terminal Peptide, Corifollitropin Alfa) in Women with World Health Organization Group II Anovulatory Infertility J. Clin. Endocrinol. Metab., December 1, 2004; 89(12): 6297 - 6304. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Lunenfeld Historical perspectives in gonadotrophin therapy Hum. Reprod. Update, November 1, 2004; 10(6): 453 - 467. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Weenen, J. E. Pena, S. V. Pollak, J. Klein, L. Lobel, R. K. Trousdale, S. Palmer, E. G. Lustbader, R. T. Ogden, and J. W. Lustbader Long-Acting Follicle-Stimulating Hormone Analogs Containing N-Linked Glycosylation Exhibited Increased Bioactivity Compared with O-Linked Analogs in Female Rats J. Clin. Endocrinol. Metab., October 1, 2004; 89(10): 5204 - 5212. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Devroey, B. C. Fauser, P. Platteau, N. G. Beckers, M. Dhont, and B. M. Mannaerts Induction of Multiple Follicular Development by a Single Dose of Long-Acting Recombinant Follicle-Stimulating Hormone (FSH-CTP, Corifollitropin Alfa) for Controlled Ovarian Stimulation before in Vitro Fertilization J. Clin. Endocrinol. Metab., May 1, 2004; 89(5): 2062 - 2070. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Perlman, B. van den Hazel, J. Christiansen, S. Gram-Nielsen, C. B. Jeppesen, K. V. Andersen, T. Halkier, S. Okkels, and H. T. Schambye Glycosylation of an N-Terminal Extension Prolongs the Half-Life and Increases the in Vivo Activity of Follicle Stimulating Hormone J. Clin. Endocrinol. Metab., July 1, 2003; 88(7): 3227 - 3235. [Abstract] [Full Text] [PDF]
|
|